NCS 613 exhibits anti-inflammatory effects on PBMCs from lupus patients by inhibiting p38 MAPK and NF-κB signalling pathways while reducing proinflammatory cytokine production

Author: Boire Gilles  

Publisher: NRC Research Press

ISSN: 1205-7541

Source: Canadian Journal of Physiology and Pharmacology, Vol.91, Iss.5, 2013-01, pp. : 353-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content